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2ABSTRACT
Acyl-CoA thioesterases (ACOTs) catalyze the hydrolysis of acyl-CoAs to free
fatty acids and coenzyme A. Recent studies have demonstrated that one gene
named Acot7, reported to be mainly expressed in brain and testis, is transcribed
in several different isoforms by alternative usage of first exons. Strongly
decreased levels of ACOT7 activity and protein in both mitochondria and cytosol
was reported in patients diagnosed with fatty acid oxidation defects, linking
ACOT7 function to regulation of fatty acid oxidation in other tissues. In this
study, we have identified five possible first exons in mouse Acot7 (Acot7a-e) and
show that all five first exons are transcribed in a tissue specific manner. Taken
together, these data show that the Acot7 gene is expressed as multiple isoforms in
a tissue specific manner, and that expression in tissues other than brain and testis
is likely to play important roles in fatty acid metabolism.
Key words: acyl-CoA thioesterase, brain, lipid metabolism, acyl-CoA hydrolase,
acyl-CoA, testis.
3INTRODUCTION
Long-chain acyl-CoA thioesterases (EC 3.1.2.2) (ACOTs) are a group of enzymes
that hydrolyze acyl-CoA esters to the free fatty acid and coenzyme A (CoASH).
The importance of ACOT enzyme activity is evident on examination of the many
different processes involving long chain acyl-CoA esters and free fatty acids.
Long-chain acyl-CoA esters play a central role in the biosynthesis of lipids, and
degradation of fatty acids via b-oxidation. It is now also apparent that, apart
from their use as an energy source, long chain acyl-CoA esters play important
roles in many other cellular processes, as reviewed (1,2). Therefore the regulation
of acyl-CoA and free fatty acids is important in intracellular metabolism.
In view of the fact that ACOT enzymes hydrolyze acyl-CoAs to free fatty acids
and CoASH, we have speculated that they are functionally linked to lipid
metabolism where they regulate intracellular levels of acyl-CoAs and free fatty
acids. Several evolutionary unrelated enzymes and protein families of Acots
have now been identified (for review see (3,4)). The peroxisome proliferator-
induced activity in mitochondria and cytosol is due to induction of two protein
families (5-7), which were named Type-I and Type-II acyl-CoA thioesterases (8).
The Type-II acyl-CoA thioesterases (now renamed Acot7  under a new
nomenclature system recently introduced (9)) in cytosol was first identified by
Miyazawa et al (5) and two of these isoforms were later cloned from rat (10,11).
These enzymes were shown to be inducible in liver and testis at both mRNA and
protein level by treatment of rats with di-(2-ethylhexyl)phthalate (DEHP), a
4peroxisome proliferator. These enzymes were shown to have a broad substrate
specificity, and could hydrolyze acyl-CoAs from C6-C22-CoA (5,8,12,13). There is
a very high sequence similarity between the rat, mouse and human ACOT7
sequences, suggesting an important evolutionary conservation of these genes.
Brain and testis contain by far the highest ACOT activities, and since 75-90% of
the activity in brain is due to ACOT7 (13), ACOT7 was also originally designated
brain acyl-CoA hydrolase (BACH) (23). In human brain, ACOT7 is expressed in
neurons, e.g pyramidal cells in the cerebral cortex and Purkinje cells in the
cerebellum (14). In developing mouse brain, Acot7 was shown to be expressed
during embryogenesis in association with neuronal differentiation (15), and in
adult mouse brain ACOT7 is exclusively localized to neurons (16). Recently, the
genomic structure of the Acot7 gene family was characterized in both human and
mouse (14,16). Although these works showed that several isoforms of Acot7 are
generated from a single gene following alternative splicing of different first
exons, with the resulting proteins being expressed mainly in brain and testis, the
function of Acot7 is still unknown in these tissues. However, recently it was
demonstrated that some patients diagnosed with fatty acid oxidation defects also
has severely decreased ACOT7 expression in fibroblasts, suggesting that ACOT7
may also have important functions outside the brain and testis in regulation of
fatty acid oxidation. Since there is almost no data available on the expression of
Acot7 isoforms in tissues besides brain and testis, we here performed a careful
expression analysis of Acot7. First we took a bioinformatics approach to
characterize the gene encoding the ACOT7 protein family in mouse. Combined
with expression profiling, real-time PCR and cellular localization experiments,
we have now identified five alternative first exons encoding isoenzymes with
5different amino-terminal protein sequences that show different cellular
localizations and distinct tissue expression patterns.
Experimental procedures
Animals and treatments
SV/129 male and female mice were maintained on a normal chow diet (R36,
Lactamin, Vadstena, Sweden). All mice were euthanized by CO2 asphyxiation,
followed by cervical dislocation. Various organs were removed and frozen in
liquid nitrogen, and stored at –70oC for preparation of total RNA. Ethical
permission was held from the Animal Experimental Ethical Committee,
Stockholm, for all animal experiments.
Identification of cytosolic and mitochondrial Acot7
A blastn sequence similarity search (17) was carried out against the entries in the
mouse Expressed Sequence Tag (EST) database (http://www.ncbi.nlm.nih.gov)
using the cDNA sequence for the human cytosolic acyl-CoA thioesterase (now
Acot7_v1) (13) as a search template. Numerous hits were aligned to the search
template and full-length sequences corresponding to mouse Acot7_v1 (previously
called CTE-II or BACHa) were assembled using DNAStar Seqman software
(DNAStar). Acot7_v1 sequences with different 5’-ends were aligned against the
sequence in ENSEBML mouse genome database (http://www.ensembl.org) to
identify the corresponding alternative first exons. By this strategy, two EST
clones with extended 5’ ends (AA466273 and AA103190) were identified. These
6clones were purchased from UK HPMG Resource Centre (Hinxton, Cambridge,
United Kingdom) and fully sequenced.
Northern blot analysis
Total RNA was prepared from the various organs using QuickPrepR total RNA
extraction kit (GE Healthcare, Uppsala, Sweden) or Ultraspec RNA kit (Biotecx
Laboratories Inc, Houston, Texas), and Northern blot analysis was carried out as
described previously (18) using a  32P-labeled full-length probe for mouse
Acot7_v2 (previously called MTE-II or BACHb) cDNA. All blots were exposed to
X-ray film at –70oC.
Antibody preparation and Western blot analysis
A peptide was synthesized based on the deduced amino acid sequence of the
carboxy-terminal end of the Acot7_v1 (Acot7a) cDNA - CKAKRQGHTEPQP-OH
(with a cysteine added at the amino-terminal end for coupling of the peptide),
which will recognize all isoforms of the Acot7 gene family. Rabbits were
immunized with 500 µg of the peptide conjugated to Keyhole Limpet
Hemocyanin, emulsified in Freund’s complete adjuvant. Booster injections of 250
µg of the peptide-conjugate emulsified in Freund’s incomplete adjuvant and
bleedings were carried out according to standard protocols. Antibodies were
affinity purified using a column with the peptide conjugated to Epoxy-activated
Sepharose 6B (GE Healthcare, Uppsala, Sweden). Western blot analysis was
carried out on 100 µg of homogenate protein (homogenized in 20 mM Tris-HCl,
pH 8.0) or 100 µg of mitochondrial and cytosolic protein prepared from various
7male and female mouse tissues and separated on 12% sodium dodecylsulfate
polyacrylamide gels (SDS-PAGE). Western blotting was performed by
electrophoretic transfer of the separated proteins onto nitrocellulose filters
(Nitropure, Micron Separations Inc., Westborough, MA) using a Transblot cell
(BioRad Laboratories, Hercules, CA). The blots were probed with the anti-
ACOT7a antibody and subsequently with horseradish peroxidase-conjugated
secondary antibody and visualized by enhanced chemiluminenscence (ECL™,
GE Healthcare) using X-ray film.
Cell transfection and cellular localization experiments
Oligonucleotides were designed based on the sequence of the full-length cDNA
for mouse Acot7_v1 and Acot7_v2 for cloning of the open reading frames as
fusion proteins with green fluorescent protein (GFP). The full-length cDNAs
were amplified from mouse kidney (Acot7_v1) and brown adipose tissue
(Acot7_v2) total RNA using One Step RNA PCR kit (AMV) (Takara Biomedicals).
Primers used were as follows: 5’ primers: Acot7_v1 (amplifies from methionine *
in Fig. 1B): 5’-AAGATGTCCGGCCCCACCAC-3’; A c o t 7 _ v 2 : 5’-
ACAATGAAGCTGCTGGTCGGGACT-3’ and the same 3’ primer for both gene
products: 5’-GGGGCTGAGGCTCTGTGTGGC-3’. Products were cloned into the
pcDNA3.1/CT-GFP vector (Invitrogen), in-frame with the GFP at the carboxy-
terminal end. Sequence analysis was performed using Big Dye Terminator (ABI
Prism, PE Biosystems) and was sequenced by Cybergene AB (Huddinge,
Sweden).
8Human skin fibroblasts were grown in Eagles Minimum Essential Medium
(Sigma, St. Louis, MO), supplemented with 10% fetal calf serum (Life
Technologies), 100 U/ml penicillin and 100 mg/ml streptomycin in an
atmosphere of 5% CO2. Approximately 1.6 x 106 cells were grown overnight in 60
mm dishes on glass cover-slips and were transfected with 10 µg Acot7_v1/CT-
GFP and Acot7_v2/CT-GFP plasmids using the calcium phosphate method as
described, but without staining of the nucleus with Hoesch 33342 (19). Briefly,
transfected cells were grown for 48 hours, fixed, and permeabilized with Triton
X-100. For mitochondrial localization, cells were preincubated for 30 mins at
37°C with 100 nM Mitotracker® Orange CMTMRos (Invitrogen Corp., CA, USA)
before permeabilization and analyzed directly. For cytosolic localization, cells
were incubated with a rabbit anti-GFP antibody (Molecular Probes, Leiden, The
Netherlands) and subsequently a CY3 conjugated affinity pure donkey anti-
rabbit IgG (Jackson ImmunoResearch). Cells were examined in Leica DM IRBE
fluroescence microscope, using Hamamatsu C4742-95 camera and C4742-95
Twain Interface software.
Quantitative Real-Time Polymerase Chain Reaction (Q-PCR)
Total RNA was isolated from various organs from male SV/129 mice using
Trizol reagent (Invitrogen Corp.). Total RNA was DNase1 treated (Promega
Corp.) and pooled from three animals. cDNA synthesis was carried out on 1mg of
pooled total RNA from each tissue, using iScript cDNA synthesis kit (Biorad).
Quantitative-polymerase chain (Q-PCR) was performed in an ABI Prism 7000
9sequence detection system, using Power Sybrgreen Master Mix (Applied
Biosystems). Primers were designed based on the cDNA sequences of the various
gene products as outlined in Table I. An endogenous control of mouse
hypoxanthine-guanine phosphoribosyl transferase (Hprt) was used. The Q-PCR
was run in singleplex in triplicate for each sample. Data were analyzed using the
ABI Prism 7000 SDS software, and the average CT value per triplicate was used to
calculate the relative amounts of each mRNA transcript, using the 2-DDCT method.
Immunoelectron microscopy
Mice were fixed by perfusion with 3% paraformaldehyde + 0.1% glutaraldehyde
in 0.1 M phosphate buffer (PB), pH 7.4. Specimens were then rinsed in 0.1 M PB,
infiltrated with 2.3 M sucrose in 0.1 M PB, placed on aluminum holders, and then
frozen in liquid nitrogen. Sectioning was performed according to Tokuyasu (20)
at -95°C. To block non-specific binding, the sections were placed on drops of 10%
bovine serum albumin (BSA, fraction V, Sigma, St. Louis, MO/USA) in 0.1 M PB
for 2 h. Subsequently, the sections were incubated with the ACOT7a primary
antibody diluted 1:100 in 0.1 M PB containing 0.1% BSA (PBB) overnight in a
humidified chamber at room temperature. Normal rabbit serum was used as
control. The sections were thoroughly washed in PBB and bound antibodies were
detected with protein A coated with 10 nm gold. The sections were then washed,
fixed in 2% glutaraldehyde in 0.1M PB for 10 min, washed in distilled water, and
embedded in 2% methyl cellulose containing 0.1% uranyl acetate (21). The grids
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were examined in a Leo 906 (Oberkochen, Germany) electron microscope at 80
kV.
RESULTS
The Acot7 gene in mouse is located on chromosome 4 E2, and it was recently
shown that the mouse and human Acot7 isoforms are encoded for by a single
gene by alternative use of different first exons, resulting in proteins with
different amino-terminal ends (14). The open reading frames are encoded for by
nine exons, with exons 2-9 being identical for all isoenzymes. Four different
alternative first exons were identified in the human gene, and 3 alternative first
exons were identified in the mouse gene (24). In an attempt to elucidate the
genomic organization of the gene encoding Acot7 in mouse, we initially searched
the mouse EST database to identify any further variations in the 5’-region. Based
on the database searches we identified 2 further possible first exons, as shown in
Fig. 1A, that would result in proteins with the amino-terminal amino acid
sequences as outlined in Fig. 1B. The remaining exons 2-9 were identical in all 5
gene products. The amino-terminal amino acid sequence of one of these variants
conforms to a mitochondrial targeting sequence (ACOT7b), whereas the other 4
isoforms encode putative cytosolic enzymes, as described below. A recent change
in nomenclature has been applied to acyl-CoA thioesterases and for the purpose
of clarity, the new nomenclature is given in Table II, as there is a different
nomenclature for gene and protein. Proteins in mouse are designated with a
lower case suffix (e.g. ACOT7a) based on exon number, whereas the gene is
designated as variant e.g. Acot1_variant 1 (Acot7_v1) etc.
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Identification and mapping of alternative first exons in the Acot7a gene
Previous work has shown that the major isoform of the Acot7 gene expressed in
brain and testis is the cytosolic Acot7_v1 (previously known as CTE-II or BACHa)
(10,13). In order to characterize the mouse gene encoding the Acot7_v1, searches
were carried out in mouse EST databases for different 5’ ends of Acot7. The EST
sequences corresponding to the different first exons were mapped and the
genomic position was also mapped by blast alignments against the mouse
genome sequence. This first exon is located most 5’ in the genomic sequence and
is denoted Exon 1a (Fig. 1A). The mouse Acot7_v1cDNA sequence was assembled
using overlapping EST sequences. Interestingly the ESTs could be divided into
two groups, one group of ESTs that would encode a shorter protein of 338 amino
acids with a calculated mass of 37.6 kDa. The deduced amino acid sequence of
the shorter ACOT7a starts Met-Ser-Gly, and contains 15 amino acids encoded for
by the first exon (as shown in Fig. 1A and B, with the start methionine indicated
by an asterisk). However, the second group of ESTs contained longer 5’-
sequences, and the EST containing the longest 5’-sequence (Accession Number
CA463703) encodes another 41 amino acids, resulting in a protein of 379 amino
acids with a calculated molecular mass of 41.6 kDa, with two further in-frame
methionines (Fig. 1A and B). Interestingly, we found four ESTs that encode the
longer ACOT protein, named ACOT7g (start methionine indicated by #)
(Accession Numbers CA463703, CA4644199, CB273453 and BY090855), three of
which were derived from testis and one from mixed tissues including testis,
respectively. In an elegant study Takagi et al showed that exon 1a contains two
tandemly located initiator elements between the second and third ATG codons
that function as transcription start sites, which could explain the presence of the
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short and long Acot7_v1 (ACOT7a) and Acot_v7 (ACOT7g) mRNAs (22). Notably,
all detected ESTs from brain encode the shorter Acot7a protein (methionine *),
suggesting that the first exon is differently transcribed in different tissues. This
was confirmed using Q-PCR, which shows that all mRNA expressed in testis
encodes Acot7_v7 (ACOT7g) (see later). This expression pattern is also in
agreement with the Western blot data, showing strong expression of two bands
in testis (see Fig. 2B).
Of the aligned blast hits, a further 8 ESTs with extended 5’ sequences of varying
lengths were assembled into a unique contig. For two of these EST clones
(AA466273 and AA103190, purchased from UK HGMP Resource Centre
(Hinxton, Cambridge, UK)) we determined the complete sequence. Sequence
analysis identified 58 amino acids in the 5’ end of these clones that were encoded
for by an alternative first exon, denoted exon 1b (Fig. 1A and B), with the
remaining 323 amino acids being identical to the mouse Acot7a sequence
(encoded for by exons 2-9). Examination of the N-terminal amino acid sequence
(PSORT II, http://psort.nibb.ac.jp) revealed that it possessed the characteristics
of a mitochondrial targeting signal, and correspond to the previously
characterized MTE-II or BACHb (8,14). The mitochondrial localization was
confirmed by green Fluorescent Protein (GFP) experiments (see below). In
addition a further EST (Accession Number BY134190) was identified that
extended further 5’, and encodes 3 more amino acids (Met-Ser-Ala) in the N-
terminal end, with the start methionine indicated underlined and in bold face
(Fig 1B). The compiled cDNA sequence for Acot7_v2 (ACOT7b) contains 1,497
bp, of which 1,152 bp encodes the open reading frame. The predicted cleavage
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site of the ACOT7b mitochondrial targeting peptide is indicated in Fig. 1B. This
putative cleavage site (V-R-TØR-A) conforms to the ‘R-2’ class of cleavage sites
[(V/A/S)-R-XØX-(S/A)] described by Schneider et al (23) and results in a mature
ACOT7b protein that is 47 amino acids shorter, with a molecular weight of 37.6
kDa, similar to the Acot7a isoform.
Identification of three further putative 1st exons
The genome alignment of the assembled mouse Acot7 EST sequences identified
three other possible 1st exons. The first exon of one of these ESTs (BI409186,
expressed in lung) maps 3’ of Exon Ia, and was denoted Exon Id. The splice
donor site of Exon Id (AAT  GAT) differs slightly to the general splice site
consensus sequence, and encodes a methionine (underlined) in BI409186 in place
of the common arginine (Fig. 1B). This methinone is the start methionine of
BI409186. The splice donor sites of the other isoforms conform more strictly to
the general consensus for splice donor sites (AAG, GAG, CCG), all of which
encode an arginine (Fig. 1B). Another exception is Exon Ic, which contains an in-
frame stop codon in the area of the putative first alternative exon, and therefore
the open reading frame starts with the first methionine in Exon II common to all
isoenzymes. Three ESTs were identified, CA535335 and CK333208 isolated from
mixed tissues, and AA275842 isolated from kidney, that are encoded by Exon Ic.
Kuramochi et al identified a 5’-RACE cDNA in mouse (called MBACH-K2),
resulting in a protein that is 29 amino acids longer in the N-terminal end (16). We
have now identified one EST (CX225643) that corresponds to a differently spliced
version of Exon Ic, lacking the in-frame stop codon (see Fig. 1B). A fifth putative
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first exon (Exon Ie) was identified based on the EST BY346013, which encodes six
amino acids (Fig. 1A and B).
The entire gene spans approximately 93.7 kb, of which exons Ia to exon II spans
about 28 kb. The sizes of the various first exons are; Ia>241 bp; Ib>252 bp; Ic>222
bp; Id>95 bp; and Ie>129 bp. Thus, the sizes of the transcripts generated by
alternative usage of the different first exons are very similar, with only about 125
bp difference between the smallest and largest transcripts. Expression of all five
first exons was verified by Q-PCR as described below.
Tissue expression of Acot7 mRNA transcripts
Previous data has shown that in rat (24) and mouse (16), the expression of the
Acot7_v1 transcript and protein is mainly confined to brain and testis. To further
investigate the tissue expression of Acot isoenzymes, we examined the mRNA
and protein levels in both male and female mouse tissues. Using a radiolabelled
full-length cDNA probe for Acot7_v2 (which will recognize all Acot7 thioesterase
isoforms), Northern blot analysis identified transcripts of slightly different sizes
in all tissues. In male mice, Acot7 expression was highest in testis, followed by
brain, but expression was also detected in lung and heart, with weak expression
in the other examined tissues (liver, muscle, spleen kidney, brown (BAT) and
white (WAT) adipose tissue (Fig. 2A). A smaller transcript was detected in brain,
lung, muscle, WAT and testis, and a slightly larger transcript was detected in
liver, kidney, heart and BAT. The larger transcript likely represents both
Acot7_v2 (mitochondrial) and the longer Acot7_v7 mRNAs, and cannot be
resolved by Northern blot analysis.
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Western blot analysis of male mouse tissue samples showed strongest expression
in brain (a band that migrates as a 43 kDa protein), followed by testis (Fig. 2B).
There is evidently a poor correlation between mRNA and protein levels in testis
and brain, with much higher protein levels in brain compared to mRNA, while
testis contains a higher amount of mRNA than protein (similar to what has
previously been reported in rat and mouse, see (11,16)), suggesting regulation
also at the post-transcriptional level. In addition, strong expression was detected
in lung, with weak expression in kidney, heart, spleen and WAT. Notably, the
major band detected in liver migrates as a 50 kDa band, similar to a second band
detected in testis. The discrepancy between calculated molecular masses (37.6
and 41.6 kDa) and migration on SDS-PAGE (43 and 50 kDa) has been described
previously (16), and is most likely due to the non-globular structure of the
ACOT7 thioesterase proteins. Domain analysis suggests that the ACOT7a
consists of two homologous domains connected by a hinge region (data not
shown).
As the individual isoforms appeared to be differently expressed in a variety to
tissues, which could not be resolved by Northern blot analysis, we therefore
carried out real-time PCR using primers specific for each of the 5 isoforms
identified. Q-PCR was carried out on pooled total RNA from liver, brain, spleen,
lung, kidney, testis and heart. Exon Ia of Acot7 contains two alternative start
methionines, resulting in proteins ACOT7a and ACOT7g, therefore primers were
designed to amplify both the Acot7_v7 (methionine# - ACOT7g) and Acot7_v1
(methionine* - ACOT7a) versions of this mRNA (methionines indicated in Fig.
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1B). Q-PCR was used to amplify both Acot7_v1 (shorter mRNA) and Acot7_v7
(longer mRNA) and calculation of the mRNA levels of the individual isoforms of
Acot7_v1 and Acot7_v7 was carried out as follows:- Primers for Acot7_v1 will
recognize both the Acot7_v1 and the Acot7_v7 isoforms, whereas primers for
Acot7_v7 are specific only for Acot7_v7, therefore if the level of expression of both
isoforms was the same in a tissue (as in testis, liver and heart), then all the
mRNA related to the Acot7_v7 (the longer mRNA). If a tissue contained different
expression levels of both these isoforms, then the net expression of the Acot7_v1
was calculated by subtracting the expression level of the Acot7_v7 from the
Acot7_v1. The Acot7_v7 is very highly expressed in testis, being 90-fold higher
than expression in brain and heart. The Acot7_v1 is mainly expressed in brain,
lung, and spleen, however, in testis all ACOT7a mRNA is accounted for by
Acot7_v7 (Fig. 3A).
Alternative splicing results in five Acot7 isoforms, three of which have not
previously been characterized, and as was evident from Northern blot analysis, it
appeared that these transcripts were differently expressed in different tissues. Q-
PCR was to used to examine if the alternative use of the first exons results in
transcripts that are expressed in different tissues. The mitochondrial Acot7_v2
(previously MTE-II or BACHb) has been described in human, but was expressed
at only very low levels in human brain compared to Acot7_v1, the cytosolic
enzyme (14). Q-PCR from mouse tissues showed that Acot7_v2 is mainly
expressed in heart and lung, with lower levels present in brain and spleen (Fig
3B). Interestingly, the three newly identified isoforms, Acot7_v3, Acot7_v4 and
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Acot7_v5 were all expressed, albeit at a low level compared to Acot7_v1 or
Acot7_v2. Acot7_v3 was highest in spleen, lung, kidney and testis whereas
Acot7_v4 was highest in brain, with detectable levels also in lung (Fig. 3C and
3D). Acot7_v5 was highest in spleen, heart and lung (Fig. 3E). It should be
emphasized that based on the Q-PCR data, it can be concluded that the Acot7_v1
and Acot7_v7 (cytosolic) are the most highly expressed isoforms, followed by the
Acot7_v2 isoform (mitochondrial), and these mRNAs are expressed to a much
higher level than the other three isoforms Acot7_v3, _v4 and _v5.
Tissue expression of Acot7 in female mice
In female mice, mRNA expression of Acot7 isoforms was highest in brain, lung,
kidney, heart and ovary (Fig. 4A). In heart and BAT, expression of a larger
transcript dominated. Western blot analysis also confirmed these findings, with
highest expression in brain, followed by lung, kidney, heart, spleen, ovary and
BAT (Fig. 4B). Q-PCR was not carried out on mRNA from female mice.
Expression of ACOT7a and ACOT7b in mitochondrial and cytosolic fractions
Due to the very high sequence similarity between Acot7 gene products, the anti-
Acot7 antibody cannot distinguish between the different isoforms. Therefore to
further distinguish between mitochondrial and cytosolic expression of ACOT7
isoforms in mice, we fractionated liver, brain, lung, spleen and heart
homogenates into mitochondria and cytosol, and analyzed these fractions by
Western blotting (Fig. 5). In mitochondria from liver, a single band of about 43
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kDa was detected, and a single band of about 50 kDa was detected in cytosol.
This confirms the expression of the longer ACOT7g protein in liver cytosol,
whereas liver mitochondria contain ACOT7b protein. We also analyzed
mitochondrial and cytosolic fractions prepared from other tissues, which showed
that it is mainly the cytosolic enzyme(s) that is/are expressed in lung, spleen and
heart. In brain there was a substantial expression of ACOT7 cytosolic proteins
and the mitochondrial ACOT7b protein. The ACOT7g protein of 50 kDa was
only detected in liver cytosol, with the cytosolic fractions from other tissues
containing only the smaller 43 kDa ACOT7 cytosolic proteins (Acot7a, 7c, 7d and
7e). Again, there was a weak correlation between protein levels and mRNA in
various tissues. ACOT7b, the mitochondrial isoform, shows highest mRNA
levels in heart, whereas low protein levels were detected in heart mitochondria.
Localization of ACOT7a and ACOT7b in cytosol and mitochondria
To examine the intracellular localization of the main ACOT7 isoforms expressed,
ACOT7a and ACOT7b, we cloned these proteins in-frame with green fluorescent
protein (GFP), which leaves the amino-terminal end accessible. We transfected
these constructs into human skin fibroblasts. Using immunofluorescence
microscopy for detection of a Tritc-labeled secondary antibody to GFP,
transfection of the ACOT7a/CT-GFP plasmid showed a strong, diffuse staining,
resembling a cytosolic localization (Fig. 6A). Direct analysis of the GFP signal
showed that ACOT7b had a distinctive pattern of expression, indicative of a
mitochondrial localization (Fig. 6B). This was confirmed using a Mitotracker
Orange™, which confirmed the structures as mitochondria (Fig. 6C). Sequence
analysis of the amino-terminal ends of the other ACOT7 isoenzymes identified
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did not reveal similarity to mitochondrial targeting signals, and are therefore
likely to be localized in cytosol.
ACOT7b is highly expressed in late spermatids in testis
As the Acot7 thioesterases are highly expressed in testis at both mRNA and
protein level, we further examined the localization of the ACOT7 protein in this
organ. Immunoelectron microscopy showed specific labeling for ACOT7b
preferentially in, and in the vicinity of, mitochondria in the late spermatids (Fig.
7A and B). Most of the labeling was detected in the mitochondria around the
sperm tail, indicating that ACOT7b protein is highly expressed in testis. Weak
labeling was detected in the surrounding cytoplasm, as well as in the cytoplasm
of surrounding cells. Labeling with normal serum was homogenously
distributed and at the background level indicating an unspecific binding.
DISCUSSION
The Acot7 gene has previously been studied in human and mouse, and shown to
be highly expressed in brain and testis. However, only little is known about the
expression in other tissues. Our recent finding that screening of patients with
undefined fatty acid oxidation deficiencies was associated with markedly
decreased ACOT7 activity and protein levels in cytosol and mitochondria (25),
suggested that these enzymes could have more diverse functions than previously
envisaged. Molecular characterization showed that the ACOT deficiency was in
fact due to decreased expression of ACOT7 in cytosol and mitochondria.
Interestingly, ACOT7 activity was responsible for about 80-90% of the total
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activity in cytosol and mitochondria in human skin fibroblasts. These data
suggest that ACOT7 expression is indeed considerable in other tissues beside
brain and testis. The aim of this study was to investigate the complex
transcriptional activity of the Acot7 gene, and to investigate the expression of
Acot7 isoforms in a broader spectrum of tissues in more detail. Here we show
that the Acot7 gene is transcribed into at least five different mRNAs in mouse,
due to the presence of five different first exons termed Exons Ia-e. Exon Ia
encodes the major brain/testis cytosolic isoenzyme, described previously from
rat and human. Using GFP fusion experiments we show that indeed this
isoenzyme is localized in cytosol. Interestingly exon 1a contains three in-frame
ATG codons, and it was shown by Takagi et al that there are two Inr elements
(Inr 1 and Inr 2) located in tandem between the second and third ATG that can
mediate transcription (22). Translation from ATG 3 would result in a protein of
338 amino acids, while translation from the first ATG results in a protein of 379
amino acids. Interestingly, exon Ia (encoding the ACOT7g 379 amino acid
protein) is highly expressed in testis, and is the main isoform expressed in liver,
kidney and heart. None of the ESTs corresponding to the Acot7_v7 was expressed
in brain tissue, in agreement with the real time data, showing that it is the
Acot7_v7 that is expressed in testis. Analysis of the amino-terminal 41 amino acid
extension did not indicate that it would constitute a mitochondrial targeting
peptide, and the cytosolic localization of this longer ACOT7g was further
strengthened by the apparent cytosolic localization of this 50-kDA protein from
fractionation of mouse liver homogenates (Fig. 5) and from GFP-localization
experiments (22). Exon Id does not contain any coding sequence and is translated
from exon 2, which results in a protein of 323 amino acids. Exon Ie encodes six
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amino acids, giving a protein of 329 amino acids in total. Exon Ib encodes the
mitochondrial isoenzyme, which was confirmed by GFP-localization
experiments. The protein was detected immunologically in liver, lung and testis
but mRNA was mainly detected in heart. Finally, splicing of exon Ic results in an
in-frame stop codon, which produces a protein of 321 amino acids. We found
three ESTs that were all spliced in this manner. However, the MBACK-K2
described by Kuramochi et al (16) is also encoded by this exon, but was spliced
123 bp further 5’, and therefore lacks the in-frame stop codon. Database searches
identified one EST from rat that corresponded to the mouse exon Ic, which was
spliced in a similar manner to the mouse gene exon Ic. In contrast, the human
gene expresses an exon that is similar to the MBACH-K2 variant, and which in
human encodes a second mitochondrial ACOT7, named human ACOT7c (14).
Recent studies have demonstrated a very high degree of sequence conservation
of the rat, mouse and human genes, which show > 95% identity at amino acid
level. However, these studies have also identified several isoenzymes of acyl-
CoA thioesterases, some of which are different in human and mouse. Therefore,
the reason for the multitude of isoenzymes formed by the alternative use of
different first exons is not yet clear. One obvious function is the expression of a
mitochondrial isoenzyme that probably plays a role in mitochondrial fatty acid
metabolism. The mitochondrial isoenzyme (ACOT7b) was identified and
characterized in rat liver as being strongly upregulated by treatment of rats with
peroxisome proliferators (8), which act as ligands for the peroxisome
proliferator-activated receptor alpha (PPARa), a nuclear receptor involved in
controlling lipid metabolism (26-29). The strong regulation of expression of
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ACOT7b in rat liver by peroxisome proliferators suggests an involvement of
ACOT7b in regulation of fatty acid metabolism. Both the cytosolic and
mitochondrial enzymes are upregulated in rat liver following this treatment
(10,11). However, it was previously shown that the cytosolic ACOT7a enzyme is
not upregulated in liver by treatment of mice with peroxisome proliferators,
indicating a species-specific responsiveness (30). Using both semi-quantitative
PCR and size-exclusion chromatography to analyze regulation of Acot7_v1 and
Acot7_v2 in livers of mice treated with the peroxisome proliferators WY-14,643 or
clofibrate, our data show only a minor induction of the mitochondrial ACOT7b
in mouse liver (both activity and mRNA) following treatment with WY-14,643 or
clofibrate, whereas no upregulation was detected in the cytosolic fraction (data
not shown). Further support for a role of ACOT7b in regulation of fatty acid
metabolism stems from our finding that ACOT7b is apparently highly expressed
in mitochondria in late spermatids, where these mitochondria are associated to
the sperm tail. These mitochondria are small, rounded and dense with
condensed matrix and expanded cristae, suggestive of high metabolic activity.
Cytosolic ACOT7 is also expressed in spermatids, but not in spermatogonia (22)
suggesting that the expression of the Acot7 gene is restricted to spermatids. In
rat, ACOT7b and/or ACOT7a expression is upregulated also in testis both at
mRNA and protein level after treatment with peroxisome proliferators (10,12).
Another further reason for the existence of numerous alternative first exons may
be to mediate tissue specific expression of Acot7. This notion is supported by our
data from the Q-PCR and Western blot analyses showing a pronounced tissue
selective expression of different transcripts and proteins. Although previous
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studies have suggested that ACOT7a is mainly localized in brain and testis in rat
(10,12,31), our study now shows that these Acot7 isoenzymes have a much
broader tissue expression in mouse than previously thought. It is evident that
different Acot7 isoenzymes are expressed in a tissue selective manner, for
example the 41.6 kDa protein is expressed in liver, testis, and although very
weakly, also in heart and brown adipose tissue. Although expression is much
higher in brain and testis than in other tissues tissues, it should be kept in mind
that the specific activity of the ACOT7 proteins are generally much higher than
the specific activities of most other ACOTs, and would therefore be likely to
significantly contribute to the cellular activity in other tissues. This is evident
from data obtained with human skin fibroblasts which showed that about 80% of
the activity in mitochondria and cytosol could be immunoprecipitated using an
anti-ACOT7 antibody (25).
Our data, and previous studies, show that there is little correlation between the
protein and mRNA expression of Acot7 in tissues, in particular when comparing
the mRNA and protein expression in brain and testis. It has been shown that
Acot7 isoenzymes account for approximately 80-90% of the acyl-CoA thioesterase
activity in brain (13,16). However, mRNA is mainly detected in testis, with lower
levels in brain and even lower levels in the other tissues, although protein is
highest in brain, followed by testis, lung and lower in the other tissues. It appears
that the poorest correlation between mRNA and protein is seen in testis. As
discussed above and by Takagi et al (22), Acot7 is specifically expressed in
spermatids, in which certain mRNAs have been reported to assemble into
messenger ribonucleoprotein particles, which temporarily repress translation.
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Such a post-transcriptional regulation of translation may play important
functions under conditions when new mRNA is not being synthesized.
Besides PPARa regulation in rat, only little is known about other factors that can
regulate transcription of the Acot7 gene. It is possible that the different first exons
may allow selective regulation of expression by various hormones or other
factors. ACOT7 expression was found to be upregulated in porcine corpus
luteum during pregnancy (32) indicating hormonal regulation, and which may
also be in line with the pronounced expression seen in mouse ovaries. Recently,
the human Acot7a promotor was found to be regulated by SREBP-2 via a sterol
regulatory element (SRE) (33), although the role of this regulation is not yet clear.
The functions of the various ACOT7 isoenzymes are not yet fully clarified. It has
been speculated that these enzymes may play a role in lipid synthesis, however,
over-expression of the ACOT7a in Chinese hamster ovary (CHO) and C3H
10T1/2 fibroblastic cells did not result in any change in phospholipid synthesis
or incorporation of palmitate into various lipid fractions in the cells (10,34).
Although some cell lines, for example CHO cells (10), express high levels of
ACOT7a, over-expression of ACOT7a in C3H 10T1/2 fibroblastic cells reduced
cell growth. Therefore, it is possible that ACOT7a does not have a general
function in regulation of acyl-CoA levels in cytosol, but rather plays a role in
cellular signaling. Acot7a shows high activity towards arachidonoyl-CoA (35),
and may therefore play a role in maintaining free arachidonic acid for signaling
via arachidonic acid, or for prostaglandin synthesis. Another interesting aspect is
that both brain and testis have a blood-tissue barrier. This barrier restricts
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lipoprotein-mediated uptake of fatty acids from the circulation and therefore
brain and testis rely on endogenous fatty acid synthesis, especially 20 and 22
carbon polyunsaturated fatty acids (PUFAs). It may be therefore that Acot7a is
involved in synthesis of complex lipids in these tissues. So far no patients have
been identified with mutations linked to any particular disorder, but a
derangement of ACOT7 protein has been detected in the hippocampus of
patients with mesial temporal lobe epilepsy (36), and decreased levels of ACOT7
protein was detected in fibroblats from patients with undefined fatty acid
oxidation disorders (25).
In conclusion, we have now identified five alternatively spliced Acot7
thioesterases, which are products of a single gene in mouse. Although these
enzymes are likely to have a similar acyl-CoA chain length specificity, similar to
the human gene family (14), it is apparent that the different first exons determine
selective tissue expression and regulation of expression.
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FIGURE LEGENDS
Fig. 1. Organization of the 5’-end of the Acot7 gene. (A) The location of the five
alternative first exons (Ia – Ie) is depicted by filled boxes, and Exon II is depicted
by an open box. Exon 1a is magnified to shown the location of two tandemly
located initiator motif element motifs (Inr) that are involved in alternative
transcription of Exon Ia. The two alternative start ATG codons are indicated by #
(encoding a 379 amino acid protein – ACOT7g) and * (encoding a 338 amino acid
protein – ACOT7a). The intron sizes were calculated from the genomic contigs
AL772240, AL 671869 and AL 611985. (B) Deduced amino acid sequences for the
N-terminal ends of the various isoenzymes produced by alternative use of
different first exons. The designation of the different first exons (Ia-e) are shown
on the far right side. The location of Exon II is indicated by a solid line [.
Predicted start methionines are underlined and in bold face. The start methionine
for the shorter version of ACOT7a is indicated by an asterisk *, whereas the start
methionine for the longer version denoted as ACOT7g is indicated by #. An
arrow indicates the predicted cleavage site for the mitochondrial targeting
peptide in Acot7b.
Fig. 2. Tissue expression of Acot7 in male SV/129 mice. (A) Total RNA was
isolated from various tissues from male SV/129 mice. Northern blot analysis was
carried out on 20 mg total RNA using an a-32P-labeled cDNA probe for Acot7_v2
as described in Experimental Procedures. BAT, brown adipose tissue; WAT,
white adipose tissue. Sizes of mRNAs are shown. (B) Western blot analysis was
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carried out on 100 mg of homogenate protein from various tissues from male
SV/129 mice, using an anti-ACOT7 antibody as described in Experimental
procedures. BAT, brown adipose tissue; WAT, white adipose tissue. The protein
size is shown in kDa.
Fig. 3. Tissue expression of Acot7 isoforms in male SV/129 mice using Q-PCR.
Tissue expression of Acot7 isoforms was investigated in mouse tissues using
single-plex Q-polymerase chain reaction (PCR). Total RNA was prepared from 3
animals, which was pooled for each tissue and cDNA was prepared from pooled
RNA samples. Q-PCR was carried out in triplicate for each tissue, using mouse
Hprt mRNA as a control. The value for pooled liver for each isoform was set to 1
and the relative expression in tissues calculated. Primers for Acot7_v1 (7a) also
recognize the Acot7_v7 (7g) as these are encoded by the same exon, however
primers for Acot7_v7 (7g) are specific for this isoform. Therefore the relative
mRNA levels of Acot7_v1 (ACOT7a) and Acot7_v7 (ACOT7g) were calculated by
subtracting the values for Acot7_v7  from the values for Acot7_v1 where
appropriate (as outlined in Results section). The amount of mRNA relative to
liver was calculated using the 2-DDCT method. (A) Acot7_v1 (ACOT7a) and
Acot7_v7 (ACOT7g) (B) Acot7_v2 (ACOT7b) (C) Acot7_v3 (ACOT7c) (D) Acot7_v4
(ACOT7d) (E) Acot7_v5 (ACOT7e).
Fig. 4. Tissue expression of ACOT7 acyl-CoA thioesterases in female SV/129
mice. (A) Total RNA was isolated from various tissues from female SV/129 mice.
Northern blot analysis was carried out on 20 mg total RNA using an a-32P-
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labeled cDNA probe for Acot7_v2 as described in Experimental Procedures. BAT,
brown adipose tissue; WAT, white adipose tissue. Sizes of mRNAs are shown.
(B) Western blot analysis was carried out on 100 mg of homogenate protein from
various tissues from female SV/129 mice, using an anti-ACOT7 antibody as
described in Experimental procedures. BAT, brown adipose tissue; WAT, white
adipose tissue. The protein size is shown in kDa.
Fig. 5. Western blot analysis of cytosolic and mitochondrial fractions from
various tissues. Western blot analysis was carried out on 100 mg of cytosolic and
mitochondrial fractions prepared from female SV/129 mice using an anti-ACOT7
antibody as described in Experimental procedures. The protein size is shown in
kDa.
Fig. 6. Cellular localization of ACOT7 thioesterases. (A) Human skin fibroblasts
transfected with ACOT7a/CT-GFP and processed for immunofluorescence
microscopy by fixation and permeabilization with 0.5% Triton X-100. The
distribution of Acot7a was examined in fibroblasts using a Tritc-labeled anti-GFP
antibody.  (B) ACOT7b/CT-GFP was examined directly by immunofluorescence
microscopy after fixation and permeabilization with 0.5% Triton X-100 (C)
Mitotracker Orange™ CMTMRos.
Fig. 7. Electron micrograph of mouse testis. (A) Early spermatids (N) and late
spermatids (arrows) containing high amount of mitochondria (B) Higher
magnification showing the distribution of labeling for ACOT7b (arrowheads) in
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mitochondria (M) and axoneme (A) of a late spermatid. Notably,
immunolabeling was only found in spermatids. Bars; A = 10 µm, B = 0.5 µm.
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Table I: Sequence of Sybrgreen primers used for Q-PCR. The 3’ primer used
was identical for each Acot7 gene product, as this primer is located in the
second exon, which is common to all genes.
Gene
product
5’ primer 3’ primer
Acot7_v1 TCCGGCCCCACCACAGACACG CCACATTGGCATCATCTGGAC
Acot7_v2 AGGGACACGGGACTTTCCCTG CCACATTGGCATCATCTGGAC
Acot7_v3 CGGGACCTCTGCCTCACTT CCACATTGGCATCATCTGGAC
Acot7_v4 CATGAGGGCTGTCAGAACCA CCACATTGGCATCATCTGGAC
Acot7_v5 CTGGGATGCTTTGGTGTCCT CCACATTGGCATCATCTGGAC
Acot7_v7 CTCCCAGGCTCATTCATTCG CCACATTGGCATCATCTGGAC
Hprt GGTGAAAAGGACCTCTCGAAGTG ATAGTCAAGGGCATATCCAACAACA
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Table II: Protein and gene nomenclature for Acot7 isoenzymes. The exon encoding
the various gene products are given. * and # refer to methionines in Fig. 1B.
Protein Nomenclature Gene Nomenclature Exon Number
ACOT7a *meth Acot7_v1 Ia
ACOT7g #meth Acot7_v7 Ia
ACOT7b Acot7_v2 Ib
ACOT7c Acot7_v3 Ic
ACOT7d Acot7_v4 Id
ACOT7e Acot7_v5 Ie
Hunt et al.
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